StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)

Close on Nov 18, 2026Market cap $4.60MP/E –Yield –

Biodexa Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Biodexa Pharmaceuticals's cash was £3.23M at Jun 30, 2026. For fiscal 2025 it was £8.53M, up 411.3% from the year before. Over ten years it grew -6.2% a year on average. The highest annual figure on record is £30.33M in fiscal 2014.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025£8.53M+411.3%
FY2024Dec 31, 2024£1.67M-72.0%
FY2023Dec 31, 2023£5.97M+110.5%
FY2022Dec 31, 2022£2.84M-71.8%
FY2021Dec 31, 2021£10.06M+33.3%
FY2020Dec 31, 2020£7.55M-30.9%
FY2019Dec 31, 2019£10.93M+366.4%
FY2018Dec 31, 2018£2.34M-82.3%
FY2017Dec 31, 2017£13.20M-25.0%
FY2016Dec 31, 2016£17.61M+8.9%
FY2015Dec 31, 2015£16.18M-46.7%
FY2014Dec 31, 2014£30.33M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026£3.23M-36.1%
Q4 FY2025Dec 31, 2025£8.53M+42.9%
Q2 FY2025Jun 30, 2025£4.04M-22.8%
Q4 FY2024Dec 31, 2024£1.67M-41.1%
Q2 FY2024Jun 30, 2024£5.06M-21.3%
Q4 FY2023Dec 31, 2023£5.97M-40.6%
Q2 FY2023Jun 30, 2023£5.23M-30.7%
Q4 FY2022Dec 31, 2022£2.84M-74.0%
Q2 FY2022Jun 30, 2022£6.42M+174.1%
Q4 FY2021Dec 31, 2021£10.06M-23.8%
Q4 FY2020Dec 31, 2020£7.55M-57.1%
Q4 FY2019Dec 31, 2019£10.93M-32.4%
Q4 FY2018Dec 31, 2018£2.34M-92.3%
Q4 FY2017Dec 31, 2017£13.20M–
Q4 FY2016Dec 31, 2016£17.61M–
Q4 FY2015Dec 31, 2015£16.18M–
Q4 FY2014Dec 31, 2014£30.33M–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?